We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

349 hedge funds and large institutions have $1.29B invested in Avanos Medical in 2015 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 123 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

27% more capital invested

Capital invested by funds: $1.02B → $1.29B (+$271M)

1% less funds holding

Funds holding: 352 → 349 (-3)

2% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 52

16% less call options, than puts

Call options by funds: $4.83M | Put options by funds: $5.74M

28% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 123

Holders
349
Holders Change
-3
Holders Change %
-0.85%
% of All Funds
9.16%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
51
Increased
88
Reduced
123
Closed
52
Calls
$4.83M
Puts
$5.74M
Net Calls
-$915K
Net Calls Change
+$3.31M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39.4M
2
CI
Cambiar Investors
Colorado
+$23.3M
3
SCM
Shapiro Capital Management
Georgia
+$17.1M
4
LCP
Lombardia Capital Partners
California
+$15.9M
5
Prudential Financial
Prudential Financial
New Jersey
+$13.2M

Top Sellers

1
RP
RR Partners
New York
-$17.9M
2
CIP
Champlain Investment Partners
Vermont
-$12.4M
3
MNA
Manning & Napier Advisors
New York
-$9.08M
4
HCM
Highbridge Capital Management
New York
-$7.94M
5
EAM
Edge Asset Management
Washington
-$6.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSV Asset Management
201
LSV Asset Management
Illinois
$30K – – –
VanEck Associates
202
VanEck Associates
New York
$29K -$4.42K -142 -14%
ACS
203
Archford Capital Strategies
Illinois
$24K +$15.5K +499 +1,721%
TRCT
204
Tower Research Capital (TRC)
New York
$23K +$21.1K +680 New
WIC
205
Woodmont Investment Counsel
Tennessee
$22K +$560 +18 +3%
EWM
206
Evercore Wealth Management
New York
$22K +$1.34K +43 +7%
TSW
207
Thompson Siegel & Walmsley
Virginia
$21K – – –
JFGIW
208
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$21K +$62 +2 +0.3%
ECM
209
Estabrook Capital Management
New York
$20.5K – – –
CTC
210
Central Trust Company
Missouri
$20K -$24.9K -801 -57%
FQ
211
First Quadrant
California
$20K – – –
WTC
212
WhitTier Trust Company
Nevada
$19K +$529 +17 +3%
WAM
213
Wealthspire Advisors (Maryland)
Maryland
$19K +$17.4K +559 New
DA
214
Dunvegan Associates
California
$17K -$404 -13 -3%
OMCS
215
Old Mutual Customised Solutions
South Africa
$17K – – –
KPCM
216
Kings Point Capital Management
New York
$16K – – –
CCS
217
Crosspoint Capital Strategies
California
$15K +$9.98K +321 New
LNB
218
Ledyard National Bank
$14K – – –
EFSCE
219
Enterprise Financial Services Corp (EFSC)
Missouri
$13K -$187 -6 -2%
PMFA
220
Plante Moran Financial Advisors
Michigan
$13K +$7K +225 +149%
DIA
221
Davidson Investment Advisors
Montana
$13K +$11.2K +359 +876%
ClearBridge Investments
222
ClearBridge Investments
New York
$12K -$585K -18,816 -98%
CGT
223
Capital Guardian Trust
California
$12K – – –
Bessemer Group
224
Bessemer Group
New Jersey
$12K +$2.21K +71 +27%
HCM
225
Highlander Capital Management
New Jersey
$11K – – –
7 8
9
10 11

AVNS Hedge Fund Activity: Q4 2015 in Review

349 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2015, worth a combined $1.29B — up 27% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of AVNS and 51 opened new positions — a net loss of 1 holder — while 123 trimmed existing stakes and 88 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $39.4M. The largest seller was RR Partners, exiting entirely with an estimated $17.9M sold.

  • 349 institutional investors held Avanos Medical (AVNS) as of Q4 2015, down from 352 in Q3 2015.
  • Funds reported $1.29B of Avanos Medical stock for Q4 2015, up 27% quarter-over-quarter.
  • 51 funds opened new Avanos Medical positions in Q4 2015 and 52 closed out, a net change of -1 holder.
  • The largest Avanos Medical buyer in Q4 2015 was T. Rowe Price Associates, an estimated $39.4M added.
  • The largest Avanos Medical seller in Q4 2015 was RR Partners, an estimated $17.9M sold.

Based on aggregated 13F filings for Q4 2015.